07:00 , Sep 10, 2001 |  BC Week In Review  |  Clinical News

Phentermine regulatory update

ABRX received FDA approval for its ANDAs for Phentermine 37.5 mg tablets, Phentermine 30 mg capsules, and Phentermine 30 mg capsules (beads) to treat obesity. Able Laboratories Inc. (ABRX), South Plainfield, N.J.   Product: Phentermine   Business:...
07:00 , Apr 24, 2000 |  BC Week In Review  |  Company News

DynaGen board of directors update

DynaGen Inc. (DYGN), Waltham, Mass.   Business: Generics   Appointed: James Klint, clinical assistant professor of medicine, hematology, at Stanford University School of Medicine   ...
07:00 , Apr 10, 2000 |  BC Week In Review  |  Company News

DynaGen board of directors update

DynaGen Inc. (DYGN), Cambridge, Mass.   Business: Generics   Appointed: Harry Silverman, EVP and CFO of Domino's Pizza LLC   ...
08:00 , Feb 14, 2000 |  BC Week In Review  |  Company News

DynaGen, Department of Veterans Affairs sales and marketing update

DYGN's Able Laboratories Inc. subsidiary (South Plainfield, N.J.) will supply VA facilities with Salsalate Tablets, a non-steroidal anti-inflammatory drug. DYGN estimates the value of the contract at $1 million over the next year. DynaGen...
07:00 , Aug 16, 1999 |  BC Week In Review  |  Company News

DynaGen sales and marketing update

DYGN subsidiary Able Laboratories Inc. (South Plainfield, N.J.) launched its NitroTab nitroglycerin sublingual tablets to treat angina pain. The product is a generic version of NitroStat from Parke-Davis (Morris Plains, N.J.). DynaGen Inc. (DYGN),...
07:00 , Jun 14, 1999 |  BC Week In Review  |  Company News

DynaGen, Gensia sales and marketing update

DYGN's Superior Pharmaceutical Co. subsidiary (Cincinnati, Ohio) will co-market Haloperidol Decanoate Injectable, an antipsychotic manufactured by GNSA's Gensia Sicor Pharmaceuticals Inc. subsidiary (Irvine, Calif.). DynaGen Inc. (DYGN), Cambridge, Mass.   Gensia Sicor Inc. (GNSA), Irvine,...
07:00 , Aug 31, 1998 |  BC Week In Review  |  Company News

DynaGen, Warner-Lambert deal

DYGN's wholly owned subsidiary, Able Laboratories Inc. (South Plainfield, N.J.), will supply Warner-Lambert with a generic version of Pyridium, a drug that treats urinary tract infections in women, for international distribution by Warner-Lambert. DynaGen...
07:00 , Aug 17, 1998 |  BC Week In Review  |  Company News

DynaGen, MOVA Laboratories Inc. deal

DYGN subsidiary Able Laboratories Inc. (South Plainfield, N.J.) will manufacture and supply DYGN's Zotrim urinary tract infection treatment exclusively to MOVA, which will distribute the product in the U.S. MOVA will provide DYGN with...
07:00 , Aug 10, 1998 |  BC Week In Review  |  Company News

DynaGen, Superior Pharmaceutical Co. deal

DYGN restructured its agreement with shareholders of Superior, a generic drug distributor acquired by DYGN in 1997 (see BioCentury, June 23, 1997). The amended agreement eliminates a $5 million stock payment to have been paid...
07:00 , May 18, 1998 |  BC Week In Review  |  Company News

DynaGen board of directors update

DynaGen Inc. (DYGN), Cambridge, Mass.   Business: Diagnostics/Imaging   Appointed: Robert Cusick as chairman, former CEO of International Murex Technology Corp.   ...